New alert system aims to cut diabetes risk in mental health patients
NCT ID NCT07264062
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether alerting clinical pharmacists about diabetes risk can help prevent type 2 diabetes in younger adults with serious mental illness. People with conditions like schizophrenia or bipolar disorder are at higher risk for diabetes, partly due to medication side effects. The study will involve about 20,000 participants and track whether more patients get recommended blood sugar tests and check-ups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SERIOUS MENTAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
KPNC Division of Research
Pleasanton, California, 94588, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Personality type may influence diabetic wound healing – a study investigates
- Can a strong support network help people with diabetic kidney disease take better care of themselves?
- Eye scan may spot hidden blood-flow changes that signal glaucoma risk in diabetes
- Tight glucose control may preserve insulin-making cells in type 2 diabetes
- A quick finger-prick test could spot hidden diabetes in rural villages
- Could chickpea flour bread tame blood sugar spikes?